100 KING STREET WEST, TORONTO, A6
Medicus Pharma Ltd. Announces Fifty-to-One Share Consolidation
Termination of Standby Equity Purchase Agreement with Yorkville
Medicus Pharma Ltd. Awards $1.45M in Cash Bonuses as Restricted Shares
Co-Development Agreement with Pfizer for CD228V Antibody-Drug Conjugate
2026 Annual Meeting Results; KPMG LLP Appointed as Auditor
Medicus Pharma Ltd. Enters $22.86M Note Purchase Agreement with Streeterville...
Annual Report to Security Holders
Amendment to Equity Distribution Agreement - Medicus Pharma Increases Offerin...
Q2
Q1
Amended Annual Report
FY 2025
Q3
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
PRER14A
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Regulation A Offering Circular Supplement (Annual Report)